> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Corrects ANDA Withdrawal Notice
- URL: https://www.fdaweb.com/fda-corrects-anda-withdrawal-notice/
- Published: 2022-04-19T12:00:00.000Z
- Updated: 2026-09-14T17:41:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151622

*Federal Register* notice: FDA is correcting a 2/28 notice announcing the withdrawal of approval of five ANDAs from multiple applicants. The notice indicated that FDA was withdrawing approval of a Jiangsu Hengrui Pharmaceuticals ANDA for gabapentin capsules. The company has since notified the agency that it does not want the ANDA withdrawn and this notice corrects this. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-04-19/pdf/2022-08299.pdf?ref=fdaweb.com).